Surgery is the primary method to treat malignant melanoma; however, the residual microtumors that cannot be resected completely often trigger tumor recurrence, causing tumor-related mortality ...

ELISA Beth Magagna was given just months to live after her back pain turned out to be cancer eating into her bones. “It’s ...

A research team has developed a diagnostic system that uses artificial intelligence (AI) to accurately identify the type of ...

A research team led by Haruyo Yamamoto, Chisa Nakashima, and Atsushi Otsuka from Department of Dermatology, Faculty of ...

A research team led by Haruyo Yamamoto, Chisa Nakashima, and Atsushi Otsuka from Department of Dermatology, Kindai University Faculty of Medicine, in ...

Like superficial spreading melanoma, lentigo maligna grows more slowly across the top layer of skin, looking like a flat or slightly raised tan, brown, or dark-brown patch.

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.

Mitotic rate ≥1/mm² and residual tumor presence are linked to higher relapse risk in cutaneous melanoma patients post-excision. Lymphovascular invasion significantly correlates with worse ...

Dermatologists recommend performing skin self-exams because they can help you find skin cancer early when it’s highly treatable.

Blackstone, HIG Capital, Nordic Capital target oncology pharma; Veritas Capital, General Atlantic raise $4.2M for melanoma research ...

UPMC Hillman Cancer Center physician scientist and melanoma researcher Yana Najjar, M.D. is the 2025 recipient of the Sy Holzer Endowed Immunotherapy Research Award to advance innovative research in ...

In the past three years, deep convolutional neural networks (DCNNs) have achieved promising results in detecting skin cancer. However, improving the accuracy and efficiency of the automatic detection ...